ProShares Global Listed Private Equity ETF
Limited financial coverage for PEX.
Not enough data to compute a meaningful composite — typical for foreign-listed ADRs, recent IPOs, or thinly-covered small caps. Live quote, chart, and any available stats still render below.
Price Chart
About the company
PEX is the third launch in the Global Private Equity Segment and is a market-cap-selected and -weighted fund, thus offering plain vanilla exposure to investors. The underlying index tracks 30 qualifying listed private equity companies which were screened based on, among other things, greater relative trading volume. Generally, the fund will invest at least 80% of its total assets in component securities of the index, and will primarily invest in common stocks of domestic and foreign companies (including in large part BDCs for US-domiciled companies) of any size.
- CEO
- Richard L. Van Kirk
- IPO
- 2013
- Employees
- 142
- HQ
- Bethesda, MD, US
Get TickerSpark's AI analysis on PEX
Create an account to generate AI analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →Already have an account? Log in
Similar companies
Peers in the same neighborhood.
- Market Cap
- $11.47M
- Div Yield
- 11.55%
- 52W High
- $28.22
- 52W Low
- $20.49
- 50D MA
- $22.60
- 200D MA
- $23.32
- Beta
- 0.80
- RSI (14)
- 63
- Avg Volume
- 2.67K
No earnings-call transcripts are available for PEX yet.
- Free Float
- 0.0%
- Shares Outstanding
- 478.16K
- Float Shares
- 0
of shares held by institutions
16 13F filers
Top institutional holders
Largest 13F positions, with quarter-over-quarter change.
| Holder | Shares | Δ Quarter |
|---|---|---|
| Reby Advisors, LLC | 105 | ▲ 105 |
Recent insider transactions
Who's buying, who's selling, and how much.
| Date | Insider | Type | Shares |
|---|---|---|---|
| Apr 22, 09 | DEUTSCHE BANK AG\ | sell | 189,500 |
| Dec 16, 08 | DEUTSCHE BANK AG\ | sell | 100,000 |
| Apr 17, 08 | DEUTSCHE BANK AG\ | buy | 100,000 |
| Apr 18, 08 | DEUTSCHE BANK AG\ | sell | 100,000 |
| Apr 8, 08 | DEUTSCHE BANK AG\ | other | 0 |
| Jun 7, 08 | DEUTSCHE BANK AG\ | other | 203,514 |
| Apr 18, 08 | DEUTSCHE BANK AG\ | sell | 100,000 |
| Apr 17, 08 | DEUTSCHE BANK AG\ | other | 0 |
| Jun 7, 07 | VAN NOSTRAND ROBERT L | other | 0 |
| Jun 7, 07 | VAN NOSTRAND ROBERT L | other | 115,000 |
A “Sell” may be a pre-scheduled 10b5-1 plan sale rather than a discretionary decision — read insider selling with that in mind.
Our PEX coverage
Recent articles, reports, and earnings notes.
No research on PEX yet
For a full analyst-grade research report — grades, price targets, financials, chart analysis — generate one on demand.
Generate PEX report →Red Light Holland Announces New Filament Health PEX010 European Research Shipment
newsfilecorp.com · Jul 16
Red Light Holland Announces Filament Health's Largest-Ever Manufacturing Run of PEX010, the Standardized and Patented Natural Psilocybin Drug Candidate Trusted Across 80+ Studies Globally, Now Offering the Widest Standardized Dosing Range, from 0.5 mg to 25 mg
newsfilecorp.com · Jul 8
Red Light Holland's Wholly Owned Subsidiary, Filament Health, Signs Agreement to Supply PEX010 Botanical Psilocybin Drug Candidate for Military Veterans PTSD Study at ARQ National Psychotrauma Centre
newsfilecorp.com · Jul 7
Red Light Holland's Wholly Owned Subsidiary, Filament Health, Signs Agreement to Supply PEX010 Botanical Psilocybin Drug Candidate for Study at GHU Paris Psychiatrie & Neurosciences in France
newsfilecorp.com · Jun 8
Red Light Holland Announces Filament Health's PEX010 Drug Candidate, the Standardized and Patented Natural Psilocybin Trusted Across 80+ Studies Globally, Selected by UCSF for Study Probing Preclinical Alzheimer's Markers
newsfilecorp.com · Jun 4
Red Light Holland Expands New Zealand Partnership with Allu Therapeutics to Advance Access to Filament Health's GMP-Compliant PEX010 Botanical Psilocybin Drug Candidate
newsfilecorp.com · May 25
Red Light Holland's Wholly Owned Subsidiary, Filament Health, Advances PEX010 Clinical Footprint with New Canadian Academic Studies in Palliative Care, Bipolar II Depression, and Healthy Adult Mechanism Research
newsfilecorp.com · May 14
Red Light Holland's Wholly Owned Subsidiary, Filament Health, Expands Distribution of PEX010 Across Canadian and U.S. Research Institutions
newsfilecorp.com · May 7
Headlines from third-party outlets — TickerSpark isn't affiliated with these sources.